USPTO serial 79297142
X-ZONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 6, 2022
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with X-ZONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Waiatarua Auckland, NZ
Waiatarua Auckland, NZ
Waiatarua Auckland, NZ
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Muscle pain relief and medicated performance gels, creams, topical sprays and roll ons; medicinal preparations for human use all in the form of balm; plant extracts for pharmaceutical purposes; medicinal herbs; medicinal oils; cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis or derivatives of cannabis, namely, resins and oils for medical or therapeutic purposes, each for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals and herbs for medicinal purposes each containing cannabis and derivatives of cannabis, namely, resins and oils, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; analgesics; topical analgesic creams; antipyretic analgesics; anti-inflammatory analgesic plasters; pain relieving creams; pain relief preparations; multi-purpose medicated analgesic balms; effervescent analgesic pharmaceutical preparations; antiseptics; bath salts for medical purposes; bath preparations for medical purposes; herbal teas for medicinal purposes; medicated capillary lotions; medicated soap; medicated shampoos; medicinal tea; mineral waters for medical purposes; tissues impregnated with pharmaceutical skin lotions; mouthwashes for medical purposes; tinctures for medical purposes; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medical purposes for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils; topical skin creams and gels, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations for medical purposes; oral sprays containing cannabis for medical purposes for use as central nervous system stimulants; topical creams, lotions, balms, oils, sprays, and transdermal patches for the relief of pain; medicinal, herbal and botanical preparations and supplements all for medical purposes in the form of oil extracts, oils, extracts, tinctures, resins, waxes, hashes, pastes, balms, salves, concentrates, lotions, sprays, ointments, pastes, tonics, liquids, powders, teas, coffees, beverages, topical skin creams, lotions and gels, pills, tablets, capsules, suppositories, skin patches, sublingual doses, and mucous membrane doses, sprays and liquids, transdermal patches and oral sprays, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; insect repellents, insecticides and insect repellents; anti-fungal creams for medical use; fungicides; after-sun creams for medical use; medicated sun tanning preparations; aloe vera gel for therapeutic purposes; anti-bacterial throat sprays and mouth washes; medicated hair care preparations and lotions; decongestants; decongestant nasal sprays; medicated body and beauty care preparations, namely, preparations in the form of creams, gels and lotions, all for the care of dry skin; dermatologicals for treatment of eczema, psoriasis and dermatological conditions; medicated bath and shower additives; medicated preparations for the care and cleaning of hair; medicated preparations for aged skin, namely, anti-aging creams and anti-aging serums; acne and skin blemish treatment medications; anti-itch creams and ointments; pharmaceutical preparations for the relief of insect bites; preparations for the treatment of burns; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; all of the aforementioned goods containing cannabis ingredients being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and no cannabidiol (CBD) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 19, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 23, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 23, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 6, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 6, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 6, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 7, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 31, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 18, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 15, 2022 | ALIE | ASSIGNED TO LIE | — |
| Aug 11, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 11, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 11, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 11, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 11, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 19, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 17, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 30, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 30, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 2, 2022 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Feb 2, 2022 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Feb 2, 2022 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jan 12, 2022 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 12, 2022 | PGRR | PETITION GRANTED - RESPONSE RECEIVED | — |
| Jan 11, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 18, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 18, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 6, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 6, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 6, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 17, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |